All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TCDA / Tricida Inc
|
|
|
|
|
|
|
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
FXF / Invesco CurrencyShares Swiss Franc Trust
|
|
|
|
|
|
|
|
GNCA / Genocea Biosciences Inc
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
/ Immunomedics, Inc.
|
|
|
|
|
|
|
|
/ Immunomedics, Inc. Call
|
|
|
|
|
|
|
|
US16706W1027 / Chiasma Inc
|
|
|
|
|
|
|
|
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
RARX / Ra Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
PFE / Pfizer Inc. Put
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd. Call
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|